<!DOCTYPE html>
<html>
<head>
<title>XOMA Royalty Corporation Quarterly report pursuant to Section 13 or 15(d)</title>
<link href="/stylesheets/ir.stockpr.css" rel="stylesheet" type="text/css">
<script type="text/javascript" src="/javascripts/ir.js"></script>
<link rel="stylesheet" type="text/css" href="https://ir.stockpr.com/stylesheets/xbrl.css">
<script type="text/javascript" src="https://ir.stockpr.com/javascripts/xbrl.min.js"></script>
<script type="text/javascript" src="https://ir.stockpr.com/javascripts/xbrl.js"></script>
</head>
<body>
<style>
body {
font-family: Arial, Helvetica, sans-serif;
font-size: 12px;
color: #454545;
}
</style>
<div class="xbrl-content">
    <h3>Quarterly report pursuant to Section 13 or 15(d)</h3>
    <div id="xbrl-menu-top">
        <div class="navigation">
            <ul class="xbrl-sf-menu">
                
                    <li>
                        <a class="menu-item " href="/sec-filings/quarterly-reports/xbrl_doc_only/2486">Cover</a>
                        <ul class="submenu">
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2486">Document and Entity Information</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="/sec-filings/quarterly-reports/xbrl_doc_only/2487">Financial Statements</a>
                        <ul class="submenu">
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2487">CONDENSED CONSOLIDATED BALANCE SHEETS</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2488">CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2489">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2490">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2491">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="/sec-filings/quarterly-reports/xbrl_doc_only/2492">Notes to Financial Statements</a>
                        <ul class="submenu">
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2492">Description of Business</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2493">Basis of Presentation and Significant Accounting Policies</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2494">Condensed Consolidated Financial Statement Detail</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2495">Licensing and Other Arrangements</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2496">Royalty and Commercial Payment Purchase Agreements</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2497">Fair Value Measurements</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2498">Lease Agreement</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2499">Common Stock Warrants</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2500">Commitments and Contingencies</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2501">Stock Based Compensation</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2502">Capital Stock</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2503">Income Taxes</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="/sec-filings/quarterly-reports/xbrl_doc_only/2504">Accounting Policies</a>
                        <ul class="submenu">
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2504">Basis of Presentation and Significant Accounting Policies (Policies)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="/sec-filings/quarterly-reports/xbrl_doc_only/2505">Notes Tables</a>
                        <ul class="submenu">
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2505">Basis of Presentation and Significant Accounting Policies (Tables)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2506">Condensed Consolidated Financial Statement Detail (Tables)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2507">Royalty and Commercial Payment Purchase Agreements (Tables)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2508">Fair Value Measurements (Tables)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2509">Lease Agreement (Tables)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2510">Common Stock Warrants (Tables)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2511">Stock Based Compensation (Tables)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2512">Capital Stock (Tables)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item current" href="/sec-filings/quarterly-reports/xbrl_doc_only/2513">Notes Details</a>
                        <ul class="submenu">
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2513">Description of Business - Liquidity (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2514">Basis of Presentation and Significant Accounting Policies - Cash and Restricted Cash (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2515">Basis of Presentation and Significant Accounting Policies - Purchase of Rights to Future Milestones and Royalties and Income Taxes and Net Income (Loss) per Share (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2516">Basis of Presentation and Significant Accounting Policies - Concentration of Risk (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2517">Condensed Consolidated Financial Statement Detail - Equity Securities (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2518">Condensed Consolidated Financial Statement Detail - Accrued and Other Liabilities (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2519">Condensed Consolidated Financial Statement Detail - Net Loss Per Share (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2520">Condensed Consolidated Financial Statement Detail - Outstanding Securities Considered Anti-Dilutive (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2521">Licensing and Other Arrangements - Novartis - NIS793 (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2522">Licensing and Other Arrangements - Novartis - VPM087 and IL-1 Beta (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2523">Licensing and Other Arrangements - Takeda (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2524">Licensing and Other Arrangements - Rezolute (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2525">Licensing and Other Arrangements - Janssen Biotech (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2526">Licensing and Other Arrangements - Affimed (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2527">Licensing and Other Arrangements - Sale of Future Revenue Streams (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2528">Royalty and Commercial Payment Purchase Agreements - Summary (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2529">Royalty and Commercial Payment Purchase Agreements - Agenus (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2530">Royalty and Commercial Payment Purchase Agreements - Bioasis (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2531">Royalty and Commercial Payment Purchase Agreements - Aronora (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2532">Royalty and Commercial Payment Purchase Agreements - Palo (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2533">Royalty and Commercial Payment Purchase Agreements - Viracta (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2534">Royalty and Commercial Payment Purchase Agreements - Kuros (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2535">Royalty and Commercial Payment Purchase Agreements - Affitech (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2536">Royalty and Commercial Payment Purchase Agreements - Summary of Royalty Receivable Activities (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2537">Fair Value Measurements - Financial Assets and Liabilities Carried at Fair Value on Recurring Basis (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2538">Fair Value Measurements - Estimated Fair Value of Equity Securities Assumptions (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2539">Fair Value Measurements - Contingent Consideration (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2540">Lease Agreement - Leased facilities (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2541">Lease Agreement - Maturity of lease liabilities (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2542">Lease Agreement - Lease costs (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2543">Lease Agreement - Additional information (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2544">Common Stock Warrants (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2545">Commitments and Contingencies - Collaborative Agreements, Royalties and Milestone Payments (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2546">Commitments and Contingencies - Contingent Consideration (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2547">Stock Based Compensation - ESPP (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2548">Stock Based Compensation - Stock Options (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2549">Stock Based Compensation - Weighted Average Assumptions (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2550">Stock Based Compensation - Stock Option Activity (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2551">Stock Based Compensation - Stock-based Compensation Expense (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2552">Capital Stock - Dividends (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2553">Capital Stock - BVF Ownership (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2554">Capital Stock - ATM Agreements (Details)</a></li>
                                                            <li><a href="/sec-filings/quarterly-reports/xbrl_doc_only/2555">Income Taxes (Details)</a></li>
                                                    </ul>
                    </li>
                            </ul>
        </div>
    </div>
    <div class="spr-xbrl-document">
        <h4>Lease Agreement - Leased facilities (Details)</h4>
                <div style="clear:both;"></div>
    </div>
</div>
</body>
</html>